Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Neurocrine BiosciencesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 21, 2026, FDA's public records list Neurocrine Biosciences, Inc with 1 OPDP letter. The most recent is an OPDP letter dated Sep 9, 2025: Untitled letter: INGREZZA.
| Date | Record | Source |
|---|---|---|
| Sep 9, 2025 | Untitled letter: INGREZZAOffice of Prescription Drug Promotion | OPDP letter |
What this company reported paying US doctors and teaching hospitals each year, $48.3M of it for research; see every company
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.